Publications 2013

Sort by: Date | Author | Title

Wegener, G. & Rujescu, D. (2013). The current development of CNS drug research. International Journal of Neuropsychopharmacology, 1-7. https://doi.org/10.1017/S1461145713000345

Wegener, G. (2013). Acta Neuropsychiatrica: A new beginning. Acta Neuropsychiatrica, 25(1), 1. https://doi.org/10.1017/neu.2012.33

Wang, G., Thomsen, K. & Frøkiær, J. (2013). Renal responses to acute volume expansion in spontaneously hypertensive rats is related to the baseline sodium excretion. Scandinavian Journal of Clinical and Laboratory Investigation. Supplement, 73(7), 529-37. https://doi.org/10.3109/00365513.2013.803232

Volke, A., Rünkorg, K., Wegener, G., Vasar, E. & Volke, V. (2013). Dual effect of nickel on L-arginine/nitric oxide system in RAW 264.7 macrophages. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2013.01.019

Videbech, P. (2013). Billeddannende metoder. In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 137-147). FADL's Forlag.

Videbech, P. (2013). Elektrokonvulsiv terapi (ECT). In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 179-195). FADL's Forlag.

Videbech, P. & Rosenberg, R. (2013). Skizofreni (F20). In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 325-369). FADL's Forlag.

Videbech, P. (2013). ADHD/hyperkinetisk forstyrrelse hos børn og voksne. In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 525-542). FADL's Forlag.

Ventorp, F., Bay-Richter, C., Janelidze, S. & Brundin, L. (2013). Exendin-4 Decreases Immobility in the Forced Swim Test in Rats Treated with Lipopolysaccharide. Biological Psychiatry, 73(9), 44S-44S.

Treccani, G., Musazzi, L., Perego, C., Milanese, M., Bonifacino, T., Lamanna, J., Malgaroli, A., Racagni, G., Bonanno, G. & Popoli, M. (2013). Stress and corticosterone increase the readily releasable pool of vesicles in rat synaptosomes of prefrontal/frontal cortex. In European Neuropsychopharmacology (suppl:2 ed., Vol. 23)

Treccani, G., Musazzi, L., Perego, C., Milanese, M., Bonifacino, T., Bonifacino, T., Lamanna, J., Malgaroli, A., Racagni, G., Drago, F., Bonanno, G. & Popoli, M. (2013). Acute stress and corticosterone increase the readily releasable pool of glutamatergic vesicles in rat synaptosomes of prefrontal/frontal cortex via mineralocorticoid and glucocorticoid receptors. Poster session presented at 26th ECNP Congress , Barcelona, Spain.

Staunstrup, N. H. & Mikkelsen, J. G. (2013). Integrase-defective lentiviral vectors-a stage for nonviral integration machineries. Current Gene Therapy.

Soubhye, J., Aldib, I., Elfving, B., Gelbcke, M., Furtmüller, P. G., Podrecca, M., Conotte, R., Colet, J.-M., Rousseau, A., Reye, F., Sarakbi, A., Vanhaeverbeek, M., Kauffmann, J.-M., Obinger, C., Nève, J., Prévost, M., Zouaoui Boudjeltia, K., Dufrasne, F. & Van Antwerpen, P. (2013). Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors. Journal of Medicinal Chemistry, 56(10), 3943-58. https://doi.org/10.1021/jm4001538

Smith, D. F., Nødskov, H., Winterdahl, M. & Lund, T. E. (2013). Replication attempt to estimate depression severity by fuzzy logic analysis of emotion-focused fMRI. Journal of Magnetic Resonance Imaging, 37(2), 498-9. https://doi.org/10.1002/jmri.23833

Smith, D. F. (2013). Benefits of flavanol-rich cocoa-derived products for mental well-being: A review. Journal of Functional Foods, 5(1), 10-15. https://doi.org/10.1016/j.jff.2012.09.002

Smith, D. F. & Jakobsen, S. (2013). Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity. Frontiers in Psychiatry, 4, 8. https://doi.org/10.3389/fpsyt.2013.00008

Smith, D. F. (2013). Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk. Frontiers in Psychiatry, (18 June 2013).

Sinning, S. & Larsen, M. T. (2013). SERT/NET selectivity of tropane compounds. Poster session presented at 6th SFB35 Symposium, Wien, Austria.

Sinning, S. (2013, Jul 2). ER DE RENE(RE)? http://newsroom.au.dk/aktuelt/tour-de-france/#news-385

Severinsen, K., Martens, P., Kristensen, K. & Sinning, S. (2013). The Serotonin transporter and its dependence on different lipid raft components. Poster session presented at 6th SFB35 Symposium, Wien, Austria.

Said, S., Ladegaard, B. & Sinning, S. (2013). Relaxing a spring-loaded transporter: Increasing the length of intracellular loop 5 domain impacts the overall function of the human serotonin transporter. Poster session presented at 6th SFB35 Symposium, Wien, Austria.

Saba, M., Jabbari, M., Moniri, R., Ziluchian Moghadam, A. & Khorshidi, A. (2013). Prevalence of vancomycin Resistant Enterococci and their phenotypes in intensive care unit patients. Abstract from European Respiratory Society (ERS) 2013 Annual Congress, Barcelona, Spain. https://erj.ersjournals.com/content/42/Suppl_57/P2199

Rucker, J. J. H., Breen, G., Pinto, D., Pedroso, I., Lewis, C. M., Cohen-Woods, S., Uher, R., Schosser, A., Rivera, M., Aitchison, K. J., Craddock, N., Owen, M. J., Jones, L., Jones, I., Korszun, A., Muglia, P., Barnes, M. R., Preisig, M., Mors, O. ... McGuffin, P. (2013). Genome-wide association analysis of copy number variation in recurrent depressive disorder. Molecular Psychiatry, 18, 183–189. https://doi.org/10.1038/mp.2011.144

Rosenberg, R. (2013). Neuropop fylder op i medierne. Politiken, debatsektionen, 6.

Rosenberg, R. (2013). Psykiatri og sure gamle mænd. Weekendavisen.

Rosenberg, R. (2013). Generaliseret angst anno 2013. BestPractice Nordic, (22), 28-32.

Rosenberg, R. (2013). Angst og depression. In E. Friis-Hasché, L. Frostholm & A. Schröder (Eds.), Klinisk Sundhedspsykologi (2. ed., pp. 139-158). Munksgaard .

Rosenberg, R. (2013). Mistænkeliggørelse af dæmonisering af antidepressiva. Ugeskrift for Læger, 175(18), 1292-1292.

Rosenberg, R. (2013). Psykoterapi og psykofarmakologi. In Psykoterapiens ABC (pp. 415-424). Psykiatrifondens Forlag.

Rosenberg, R. & Videbech, P. (2013). Klinisk neuro-psykiatri: Fra molekyle til sygdom. (2 ed.) FADL's Forlag.

Rosenberg, R. (2013). Neuropsykiatri - kort historisk tilbageblik. In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 11-22). FADL's Forlag.

Rosenberg, R. (2013). Neuropsykiatri - definition, afgrænsning og sygdomsopfattelse. In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 23-33). FADL's Forlag.

Rosenberg, R. (2013). Centralnervesystemets struktur og funktion - en introduktion. In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 35-49). FADL's Forlag.

Rosenberg, R. (2013). Evolutionsteori og psykiatri. In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 51-68). FADL's Forlag.

Rosenberg, R. & Wegener, G. (2013). Stressbegreber i neuropsykiatri. In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 69-86). FADL's Forlag.

Rosenberg, R. & Buttenschøn, H. N. (2013). Psykiatrisk genetik. In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 83-105). FADL's Forlag.

Rosenberg, R. & Videbech, P. (2013). Neuropsykiatrisk undersøgelse. In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 107-122). FADL's Forlag.

Rosenberg, R. & Wegener, G. (2013). Psyko- og neurofarmakologi. In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 149-178). FADL's Forlag.

Rosenberg, R. (2013). Psykiske lidelser forårsaget af alkohol og andre psykoaktive stoffer (F1). In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 299-324). FADL's Forlag.

Rosenberg, R. & Videbech, P. (2013). Nervøse og stress-relaterede tilstande samt tilstande med psykisk betingede legemlige symptomer (F4). In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 411-458). FADL's Forlag.

Rosenberg, R. & Videbech, P. (2013). Anorexia nervosa og bulimia nervosa (F50). In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 459-474). FADL's Forlag.

Rosenberg, R. (2013). Specifikke forstyrrelser af personlighedsstruktur (F6). In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 495-524). FADL's Forlag.

Rosenberg, R. (2013). Psykiatri 1913-2013: fra asyl til hjernevidenskab og sundhedspolitik. In 100 års strejftog i lægekunsten: Jydsk Medicinsk Selskab 1913-2013 (pp. 101-127). Jydsk Medicinsk Selskab.

Rosenberg, R. (2013). Psykiatriske diagnoser og klassifikation anno 2013. BestPractice Nordic, 6(23), 16-18.

Rosenberg, R. (2013). Den akut psykotiske patient. In O. B. Schaffalitzky de Muckadell, S. Haunsø & H. Vilstrup (Eds.), Medicinsk Kompendium (18 ed., Vol. 1, pp. 265-268). Nyt Nordisk Forlag Arnold Busck.

Rosenberg, R. (2013). Psykoaktive stoffer - skadeligt brug og afhængighed. In O. B. Schaffalitzky de Muckadell, S. Haunsø & H. Vilstrup (Eds.), Medicinsk Kompendium (18 ed., Vol. 2, pp. 2693-2705). Nyt Nordisk Forlag Arnold Busck.

Rezaei, M., Moniri, R., Mousavi, S. G. A. & Jabbari, M. (2013). Prevalence of Biofilm Formation Among Methicillin Resistance Staphylococcus aureus Isolated From Nasal Carriers. Jundishapur Journal of Microbiolog.

Rajkumar, A. P., Brinda, E. M., Duba, A. S., Thangadurai, P. & Jacob, K. S. (2013). National suicide rates and mental health system indicators: An ecological study of 191 countries. International Journal of Law and Psychiatry. Advance online publication. https://doi.org/10.1016/j.ijlp.2013.06.004

Popoli, M., Musazzi, L. & Treccani, G. (2013). The stress impact on glutamate transmission: a key to mood and anxiety disorders. In European Neuropsychopharmacology (Suppl2 ed., Vol. 23)

Pereira, V. S., Wegener, G. & Joca, S. R. (2013). NMDA antagonist, but not nNOS inhibitor, requires AMPA receptors in the ventromedial prefrontal cortex (vmPFC) to induce antidepressant-like effects. Acta Neuropsychiatrica, 25(1), 25-26. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L71159559 http://dx.doi.org/10.1017/neu.2013.10 http://wx7cf7zp2h.search.serialssolutions.com?sid=EMBASE&issn=09242708&id=doi:10.1017%2Fneu.2013.10&atitle=NMDA+antagonist%2C+but+not+nNOS+inhibitor%2C+requires+AMPA+receptors+in+the+ventromedial+prefrontal+cortex+%28vmPFC%29+to+induce+antidepressant-like+effects&stitle=Acta+Neuropsychiatr.&title=Acta+Neuropsychiatrica&volume=25&issue=1&spage=25&epage=26&aulast=Pereira&aufirst=Vitor+Silva&auinit=V.S.&aufull=Pereira+V.S.&coden=&isbn=&pages=25-26&date=2013&auinit1=V&auinitm=S.

Displaying results 1 to 50 out of 122

Revised 31.01.2023

Karen Jul Madsen